Back to VA VANGUARD CAPITAL MANAGEMENT LLC
ANTX2 quarters
Position history for VAVANGUARD CAPITAL MANAGEMENT LLC's holdings in AN2 THERAPEUTICS INC
Yes. Vanguard Capital Management holds 1,238,705 shares of ANTX (AN2 Therapeutics), worth $6M, as of its Q2 2026 13F filing. It increased the position by 227,627 shares (+22.5%) from Q1 2026. Vanguard Capital Management has held ANTX in every 13F on record since Q1 2026, 2 quarterly filings.
Current Value
$6M
Current Shares
1.2M
Total Value Change
+$2.5M
Total Shares Change
+227,627
Quarter-by-Quarter History
Other major holders of ANTX: RA CAPITAL MANAGEMENT, L.P.